AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance ...

Since 2023, AstraZeneca has invested more than USD1.7 billion to expand its production in China, including spending USD750 million to build a new inhaler production base in Qingdao, eastern Shandong ...

AstraZeneca's five-year US$2.5 billion investment, announced on Friday, includes a new research-and-development center in Beijing and a research agreement with Harbour BioMed. The U.K. firm will also ...

China's economic transition is gaining momentum as initiatives to boost consumption and drive innovation take center stage, ...

We will probably not have any clarification on how the reciprocal tariffs will play out until April 2 — provided Trump isn’t ...

BEIJING: Chinese Premier Li Qiang urged countries to open their markets to combat “rising instability and uncertainty” at a ...

Chinese Premier Li Qiang urged countries to open their markets to combat “rising instability and uncertainty” at a business ...

The death toll in Gaza has passed the 50,000 mark as Israel expanded its fighting in the Palestinian enclave on Sunday.

Guests to the China Development Forum 2025 pose for a group photo on March 23, 2025 in Beijing ahead of the opening ceremony ...

Major news from Europe included earnings and investment updates. AstraZeneca ( AZN) is expanding its footprint in China with an investment of $2.5B in Beijing over the next five years to build its ...

Discover the top gainers and losers in the S&P 500 Healthcare Index and stay updated on major news like J&J's $55B investment and Pfizer's Haleon stake exit.

On day one of the China Development Forum on Sunday, Chinese premier Li Qiang urged countries to combat “rising instability ...